✦ LIBER ✦

Analysis for Prognostic Factors of 60-day Mortality: Evaluation of an Irinotecan-Based Phase III Trial Performed in the First-Line Treatment of Metastatic Colorectal Cancer

✍ Scribed by Clemens Giessen; Sebastian Stintzing; Ruediger Paul Laubender; Donna Pauler Ankerst; Christoph Schulz; Nicolas Moosmann; Dominik Paul Modest; Andreas Schalhorn; Ludwig Fischer von Weikersthal; Volker Heinemann

Book ID: 116365617
Publisher: CIG Media Group, LP.
Year: 2011
Tongue: English
Weight: 295 KB
Volume: 10
Category: Article
ISSN: 1533-0028
DOI: 10.1016/j.clcc.2011.03.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase 2b, Double-Blind, Randomized Stu

A Phase 2b, Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Sorafenib (SOR) Compared With Placebo (PBO) When Administered in Combination With Chemotherapy (Modified FOLFOX6) for First-line Treatment (tx) of Patients (Pts) With Metastatic Colorectal Cancer (mCRC). The RESPECT Trial

✍ J. Tabernero; R. Garcia-Carbonero; C.H. Könne; P.J. O'Dwyer; A. Sobrero; E. Van 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB